MIRA Pharmaceuticals Shares Are Trading Higher After the Company Announced New Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2
MIRA藥品公司宣佈其新型口服氯胺酮類似物Ketamir-2的新臨床研究結果後,其股票價格上漲。
MIRA Pharmaceuticals Shares Are Trading Higher After the Company Announced New Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2
MIRA藥品公司宣佈其新型口服氯胺酮類似物Ketamir-2的新臨床研究結果後,其股票價格上漲。
使用瀏覽器的分享功能,分享給你的好友吧